Skip to main content

Breast Cancer - Adjuvant News (Page 11)

Text Message Outreach Can Help Increase Mammogram Completion Rates

MONDAY, May 6, 2024 – Text messaging women after initial outreach for breast cancer screening increases mammogram completion rates, according to a study published online May 6 in JAMA Internal...

FDA Approves Genentech’s Perjeta (Pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer

South San Francisco, CA – December 20, 2017 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Perjeta ® ...

FDA Approves Nerlynx (neratinib) for Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer

July 17, 2017 – The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer

Related drug support groups

letrozole, Herceptin, Femara, tamoxifen, trastuzumab